2009. Economic evaluation of temsirolimus on the basis of the results of the ARCC (Advanced Renal-Cell Carcinoma) study. Farmeconomia. Health Economics and Therapeutic Pathways. 10, 2 (Jun. 2009), 93–97. DOI:https://doi.org/10.7175/fe.v10i2.167.